| Name: | Atracurium Besylate Impurity D1 Iodide |
| Catalogue No. | VE008034 |
| CAS No. | N/A |
| Molecular Formula | C29H42NO7. I |
| Molecular Weight | 643.55 g/mol |
| Status | In-Stock |
| IUPAC Name | (1R,2S)-1-(3,4-dimethoxybenzyl)-2-(3-((5-hydroxypentyl)oxy)-3-oxopropyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium iodide |
| Description | Atracurium Besylate Impurity D1 Iodide (CAS No: N/A) or (1R,2S)-1-(3,4-dimethoxybenzyl)-2-(3-((5-hydroxypentyl)oxy)-3-oxopropyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium iodide, it acts as antagonizes the neurotransmitter action of acetylcholine by binding competitively with cholinergic receptor sites on the motor end-plate |
| References | Chalermkitpanit, Pornpan, et al. “Determination of Dose and Efficacy of Atracurium for Rapid Sequence Induction of Anesthesia: A Randomised Prospective Study.” Journal of Anaesthesiology, Clinical Pharmacology, vol. 36, no. 1, 2020, pp. 37–42, www.ncbi.nlm.nih.gov/pmc/articles/PMC7047700/, 10.4103/joacp.JOACP_36_19. |
